APA

Azzopardi N., Dupuis-Girod S., Ternant D., Fargeton A., Ginon I., Faure F., Decullier E., Roux A., Carette M., Gilbert-Dussardier B., Hatron P., Lacombe P., Leguy-Seguin V., Rivière S., Corre R., Bailly S. & Paintaud G. (20160322). Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. : mAbs.

Chicago

Azzopardi Nicolas, Dupuis-Girod Sophie, Ternant David, Fargeton Anne-Emmanuelle, Ginon Isabelle, Faure Frédéric, Decullier Evelyne, Roux Adeline, Carette Marie-France, Gilbert-Dussardier Brigitte, Hatron Pierre-Yves, Lacombe Pascal, Leguy-Seguin Vanessa, Rivière Sophie, Corre Romain, Bailly Sabine and Paintaud Gilles. 20160322. Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. : mAbs.

Harvard

Azzopardi N., Dupuis-Girod S., Ternant D., Fargeton A., Ginon I., Faure F., Decullier E., Roux A., Carette M., Gilbert-Dussardier B., Hatron P., Lacombe P., Leguy-Seguin V., Rivière S., Corre R., Bailly S. and Paintaud G. (20160322). Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. : mAbs.

MLA

Azzopardi Nicolas, Dupuis-Girod Sophie, Ternant David, Fargeton Anne-Emmanuelle, Ginon Isabelle, Faure Frédéric, Decullier Evelyne, Roux Adeline, Carette Marie-France, Gilbert-Dussardier Brigitte, Hatron Pierre-Yves, Lacombe Pascal, Leguy-Seguin Vanessa, Rivière Sophie, Corre Romain, Bailly Sabine and Paintaud Gilles. Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. : mAbs. 20160322.